<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Yerly S</dc:creator>
  <dc:creator>Perrin L</dc:creator>
  <dc:creator>Van Delden C</dc:creator>
  <dc:creator>Schaffer S</dc:creator>
  <dc:creator>Thamm S</dc:creator>
  <dc:creator>Wunderli W</dc:creator>
  <dc:creator>Kaiser L</dc:creator>
  <dc:date>2007</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">BACKGROUND
Sensitive quantitation of cytomegalovirus (CMV) DNA in blood is helpful for the diagnosis of CMV infection or reactivation and the monitoring of transplanted patients.


OBJECTIVES
We compared a new PCR assay coupled with an automated extraction system (CMV real-time PCR, Abbott Molecular, Des Plaines, IL, USA) to a previously validated method (ultrasensitive Cobas Amplicor CMV DNA Monitor, Roche Molecular, Indianapolis, IN, USA).


RESULTS
Using limiting dilutions of CMV DNA positive plasma, the two assays had a similar detection threshold ranging between 20 and 45 copies/ml. Coefficients of variation of CMV real-time PCR assay varied from 1 to 12% for CMV DNA levels between 10,000 and 20 copies/ml. Viral loads assessed by the two methods on 179 clinical samples showed an overall concordance of 89% and an excellent correlation (R=0.94). Discrepancies were only observed for samples with low CMV DNA levels (&lt;300 copies/ml); 18 samples were positive by CMV real-time PCR only, and 2 samples by ultrasensitive Cobas CMV only. Values obtained by CMV real-time PCR were on average 0.4 log higher than those of ultrasensitive Cobas CMV. Successive samples of transplanted patients with evidence of CMV infection/reactivation revealed that CMV real-time PCR assay was positive earlier and for a longer period of time after treatment initiation.


CONCLUSIONS
Although both assays had similar analytical performances, the CMV real-time PCR assay has the advantages of automated extraction and higher dynamic range, and shows a trend for an improved sensitivity that might impact on clinical decisions.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/89445</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jcv.2007.01.003</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/17321200</dc:relation>
  <dc:source>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. - 2007</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Analysis of Variance</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Cytomegalovirus</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">DNA, Viral</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Plasma</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Polymerase Chain Reaction</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Reproducibility of Results</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Sensitivity and Specificity</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Viral Load</dc:subject>
  <dc:title xmlns:ns12="xml" ns12:lang="en">Cytomegalovirus quantification in plasma by an automated real-time PCR assay.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
